Vivani Medical price target lowered to $3.50 from $4 at H.C. Wainwright

H.C. Wainwright has reduced its price target for Vivani Medical (VIVN) from $4 to $3.50, reflecting a minor adjustment in analyst expectations for the small-cap medical device company.

• H.C. Wainwright lowers price target for Vivani Medical
• New target of $3.50 from $4